- #36
Phil Core
- 68
- 17
1. Spike Proteins of SARS-CoV and SARS-CoV-2 Utilize Different Mechanisms to Bind With Human ACE2 - https://www.frontiersin.org/articles/10.3389/fmolb.2020.591873/full This article examines the differences between SARS-CoV and SARS-CoV-2
S protein plays a crucial role in SARS-CoV-2 infection by binding to human ACE2. To understand the mechanisms of how S protein binds to ACE2, we compared SARS-CoV with SARS-CoV-2 in biophysical features such as electrostatic binding forces, electric field lines, salt bridges, and hydrogen bonds. We found that even though SARS-CoV and SARS-CoV-2 share very similar structures, there are significant differences in the process when their S proteins bind to ACE2. The common feature is that the calculations of electrostatic surfaces and electric field lines at the binding interfaces demonstrated that ACE2 has a negatively charged binding surface while S protein RBDs are overall positively charged, which provides dominantly attractive forces between ACE2 and S proteins. The differences of electrostatic features between SARS-CoV and SARS-CoV-2 are analyzed in various perspectives as well in this work. Comprehensive analyses were also performed after 100 ns MD simulations, which indicates that SARS-CoV-2 has more high-occupancy (>90%) hydrogen bonds at the interface area between its S protein RBD and ACE2 than SARS-CoV. The electric field line related residues are distributed quite differently, which results in a more robust binding strategy of SARS-CoV-2. Also, the SARS-CoV-2 has higher electric field line density than that of SARS-CoV, which indicates stronger interaction between SARS-CoV-2 and ACE2, compared to that of SARS-CoV. Those facts make the interactions of SARS-CoV-2 more robust than SARS-CoV, which may explain why COVID-19 spreads faster than SARS in 2003."
2. In the Andersen article he states - "Andersen notes – “SARS-CoV-2 appears to be "optimized" for binding to the human receptor ACE2” (via random mutation and natural selection.)
3. The references article by Dalgleish and Sorensen give an example of how the changes in SARS-CoV-2 might have came about.
The statement made in the article about the sequence of positively charged amino acids may be wrong. However, I still found the diagrams provided to be very stimulating. I will be very interested to see how their article is received in the scientific community. They both seem to have a firm grasp on this area of inquiry.
4. "However, we have plenty of examples of the SARS-CoV-2 gaining naturally mutations that increase its transmissibility and decrease its succeptibility to antibodies as it spreads among humans" I do not believe theses mutations are of the same magnitude as mutations needed to mutate viruses found in bats to the Cov-2 in humans.
Conclusion
S protein plays a crucial role in SARS-CoV-2 infection by binding to human ACE2. To understand the mechanisms of how S protein binds to ACE2, we compared SARS-CoV with SARS-CoV-2 in biophysical features such as electrostatic binding forces, electric field lines, salt bridges, and hydrogen bonds. We found that even though SARS-CoV and SARS-CoV-2 share very similar structures, there are significant differences in the process when their S proteins bind to ACE2. The common feature is that the calculations of electrostatic surfaces and electric field lines at the binding interfaces demonstrated that ACE2 has a negatively charged binding surface while S protein RBDs are overall positively charged, which provides dominantly attractive forces between ACE2 and S proteins. The differences of electrostatic features between SARS-CoV and SARS-CoV-2 are analyzed in various perspectives as well in this work. Comprehensive analyses were also performed after 100 ns MD simulations, which indicates that SARS-CoV-2 has more high-occupancy (>90%) hydrogen bonds at the interface area between its S protein RBD and ACE2 than SARS-CoV. The electric field line related residues are distributed quite differently, which results in a more robust binding strategy of SARS-CoV-2. Also, the SARS-CoV-2 has higher electric field line density than that of SARS-CoV, which indicates stronger interaction between SARS-CoV-2 and ACE2, compared to that of SARS-CoV. Those facts make the interactions of SARS-CoV-2 more robust than SARS-CoV, which may explain why COVID-19 spreads faster than SARS in 2003."
2. In the Andersen article he states - "Andersen notes – “SARS-CoV-2 appears to be "optimized" for binding to the human receptor ACE2” (via random mutation and natural selection.)
3. The references article by Dalgleish and Sorensen give an example of how the changes in SARS-CoV-2 might have came about.
The statement made in the article about the sequence of positively charged amino acids may be wrong. However, I still found the diagrams provided to be very stimulating. I will be very interested to see how their article is received in the scientific community. They both seem to have a firm grasp on this area of inquiry.
4. "However, we have plenty of examples of the SARS-CoV-2 gaining naturally mutations that increase its transmissibility and decrease its succeptibility to antibodies as it spreads among humans" I do not believe theses mutations are of the same magnitude as mutations needed to mutate viruses found in bats to the Cov-2 in humans.